Evaluation of teplizumab's efficacy and safety in treatment of type 1 diabetes mellitus: A systematic review and meta-analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

136

HTML

1295

Figures (1-6)

109

Tables (1-3)

Sum=1638

Publishing Process of This Article

Item

Count

Browse

Download

133

Sum=160

Jul 15, 2024 (publication date) through Nov 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Diabetes. Jul 15, 2024; 15(7): 1615-1626
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1615

Full Size Figure Download Figure

Figure 5 Forest plot for risk of adverse events in teplizumab vs control group. df: Degree of freedom; M-H: Mantel-Haenszel.

Citation: Ma XL, Ge D, Hu XJ. Evaluation of teplizumab's efficacy and safety in treatment of type 1 diabetes mellitus: A systematic review and meta-analysis. World J Diabetes 2024; 15(7): 1615-1626
URL: https://www.wjgnet.com/1948-9358/full/v15/i7/1615.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i7.1615